José Antonio López‐Guerrero

Author

Fundación Instituto Valenciano de Oncología ORCID

Also Known As

Ana Vivancos, Guillermo López-Doménech, J A Lopez Guerrero, J A Lopez-Guerrero, J A López-Guerrero, J A López‐Guerrero, J. A. Guerrero, J. A. Lopez-Guerrero, J. A. López-Guerrero, J. A. López‐Guerrero

326

Publications

9.2K

Citations

H-Index

151

Concepts

All Affiliations

Fundación Instituto Valenciano de Oncología Universitat de València Universidad Autónoma de Madrid Centro de Biología Molecular Severo Ochoa Consejo Superior de Investigaciones Científicas

About

José Antonio López‐Guerrero is an author at Fundación Instituto Valenciano de Oncología specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	59	2.1K
2	Public Health	6	6	147
3	Health Sciences	5	5	94
4	Engineering	3	3	378
5	Social Sciences	1	1	11

José Antonio López‐Guerrero

116

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Deletions Affecting Codons 557-558 of the <i>c</i>-<i>KIT</i> Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS) Javier Martín‐Broto, Andrés Poveda, Antonio Llombart‐Bosch, Journal of Clinical Oncology	2005	350
DNA Source Selection for Downstream Applications Based on DNA Quality Indicators Analysis Gema Lucena-Aguilar, Ana María Sánchez-López, Cristina Barberán-Aceituno, Biopreservation and Biobanking EngineeringGeneticsDna AnalysisNucleic Acid Amplification TestGenomics	2016	263
Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors B. Llombart, Carlos Monteagudo, Onofre Sanmartín, Journal of the American Academy of Dermatology	2011	129
Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy Irene Casanova‐Salas, J. Rubio‐Briones, Ana Calatrava, The Journal of Urology	2014	124
Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (<i>COL1A1‐PDGFB </i>) study with therapeutic implications B. Llombart, Onofre Sanmartín, José Antonio López‐Guerrero, Histopathology	2009	101
Induction of Programmed Cell Death by Parvovirus H-1 in U937 Cells: Connection with the Tumor Necrosis Factor Alpha Signalling Pathway Béatrice Rayet, José Antonio López‐Guerrero, Jean Rommelaere, Journal of Virology	1998	99
Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas María del Carmen González-Vela, Soraya Curiel‐Olmo, Sophia Derdak, Journal of Investigative Dermatology	2016	97
Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase‐polymerase chain reaction and fluorescence in situ hybridization methodologies Rocío Salgado, B. Llombart, Ramón M. Pujol, Genes Chromosomes and Cancer	2011	96
A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer Ann Rita Halvorsen, Maria Moksnes Bjaanæs, Marissa LeBlanc, Oncotarget	2016	95
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network Manuel M. Morente, R. Mager, S. Alonso, European Journal of Cancer Tissue CollectionQuality ControlSurgeryFrozen Section ProcedureBiomedical Engineering	2006	90

Page 1